Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Psychosomatic Medicine2007Vol. 69(7), pp. 587–596
Citations Over TimeTop 1% of 2007 papers
James A. Blumenthal, Michael A. Babyak, P. Murali Doraiswamy, Lana L. Watkins, Benson M. Hoffman, Krista A. Barbour, Steve Herman, W. Edward Craighead, Alisha L. Brosse, Robert Waugh, Alan L. Hinderliter, Andrew Sherwood
Abstract
The efficacy of exercise in patients seems generally comparable with patients receiving antidepressant medication and both tend to be better than the placebo in patients with MDD. Placebo response rates were high, suggesting that a considerable portion of the therapeutic response is determined by patient expectations, ongoing symptom monitoring, attention, and other nonspecific factors.
Related Papers
- → Placental Passage of Antidepressant Medications(2003)382 cited
- → Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder(2000)259 cited
- → Fluoxetine versus sertraline and paroxetine in major depression: Long-term changes in weight(1998)7 cited
- Systematic review of sertraline versus fluoxetine in treatment for depression(2010)
- Analysis of prescriptions of three selective serotonin reuptake inhibitors from a perspective of metabolic interactions(2004)